TRCT
PATH icon

Tower Research Capital (TRC)’s UiPath PATH Stock Holding History

Tower Research Capital (TRC)’s Portfolio PATH Stock Details PATH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$167K Buy
15,071
+13,093
+662% +$167K ﹤0.01% 1754
2025
Q4 		$32.4K Sell
1,978
-718
-27% -$11.2K ﹤0.01% 2750
2025
Q3 		$36.1K Buy
2,696
+1,109
+70% +$13.1K ﹤0.01% 2780
2025
Q2 		$20.3K Sell
1,587
-10,655
-87% -$128K ﹤0.01% 3671
2025
Q1 		$126K Buy
12,242
+11,539
+1,641% +$148K ﹤0.01% 1645
2024
Q4 		$8.94K Sell
703
-48
-6% -$634 ﹤0.01% 3952
2024
Q3 		$9.61K Sell
751
-57,719
-99% -$707K ﹤0.01% 3853
2024
Q2 		$741K Buy
58,470
+56,005
+2,272% +$968K 0.01% 1007
2024
Q1 		$55.9K Buy
2,465
+2,251
+1,052% +$52.7K ﹤0.01% 2200
2023
Q4 		$5.32K Sell
214
-1,897
-90% -$37K ﹤0.01% 4853
2023
Q3 		$36.1K Sell
2,111
-5,445
-72% -$90.7K ﹤0.01% 2850
2023
Q2 		$125K Sell
7,556
-52,100
-87% -$836K ﹤0.01% 1896
2023
Q1 		$1.05M Buy
59,656
+28,932
+94% +$437K 0.03% 419
2022
Q4 		$391K Sell
30,724
-85,123
-73% -$1.05M 0.02% 848
2022
Q3 		$1.46M Buy
115,847
+65,314
+129% +$1.15M 0.02% 542
2022
Q2 		$919K Buy
50,533
+29,645
+142% +$554K 0.02% 748
2022
Q1 		$451K Buy
20,888
+19,772
+1,772% +$666K ﹤0.01% 1203
2021
Q4 		$48K Buy
1,116
+210
+23% +$10.4K ﹤0.01% 2791
2021
Q3 		$48K Sell
906
-2,115
-70% -$128K ﹤0.01% 2999
2021
Q2 		$205K Buy
+3,021
New +$222K 0.01% 1904

Other funds holding PATH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Tower Research Capital (TRC)'s PATH Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its UiPath (PATH) stake by 662% in Q1 2026, buying an estimated $167K and bringing the position to 15,071 shares worth $167K. The position accounts for ﹤0.01% of the portfolio, ranked #1754.

Tower Research Capital (TRC) first reported a position in PATH in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.46M in Q3 2022. 533 funds tracked by Wall St. Rank hold PATH as of Q1 2026.

  • Tower Research Capital (TRC) held 15,071 shares of UiPath worth $167K as of Q1 2026.
  • Tower Research Capital (TRC) bought 13,093 UiPath shares in Q1 2026, an estimated $167K.
  • UiPath made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #1754 holding.
  • Tower Research Capital (TRC) first reported a position in UiPath in Q2 2021 and has held it in 20 quarters since.
  • Tower Research Capital (TRC)'s UiPath position peaked at $1.46M in Q3 2022.
  • 533 funds tracked by Wall St. Rank held UiPath as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.